PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Delayed metformin treatment improves functional recovery following traumatic brain injury via central AMPK-dependent brain tissue repair.

Mouse / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32858129 ↗2020Reported benefit

Delayed metformin treatment improves functional recovery following traumatic brain injury via central AMPK-dependent brain tissue repair.

MouseTBICryogenicC57BL/6maleintraperitoneal20, 50 or 100 mg/kg/day (100 mg/kg/day effective)delayed post-injury, initiated at day 1, day 3 or day 5 after cTBI

Model: Cryogenic traumatic brain injury (cTBI)

Metformin 100 mg/kg/day given day 1-14, day 1-10 or day 3-10 improved motor functional recovery and reduced infarct volume, whereas day 1-2 or day 5-12 dosing did not; extending treatment from day 5 to 2 weeks (day 5-28) restored benefit, indicating a therapeutic window of at least 5 days. Benefit…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.65. Machine-extracted fields require source verification.